One trial showed an effect of donepezil on cognition after 24 weeks ( 4 ), while the other trials failed to reach statistical significance on the primary endpoint ( 2 ).
← all excerpts
Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment.
1
—
—